{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:04:18Z","timestamp":1768345458476,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.nmd.2022.06.011","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T23:28:19Z","timestamp":1656545299000},"page":"743-748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cognitive assessment in patients with myotonic dystrophy type 2"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-556X","authenticated-orcid":false,"given":"Stojan","family":"Peric","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilija","family":"Gunjic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Delic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivera","family":"Stojiljkovic Tamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Salak-Djokic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovan","family":"Pesovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Petrovic Djordjevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vukan","family":"Ivanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusanka","family":"Savic-Pavicevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Meola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidosava","family":"Rakocevic-Stojanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2022.06.011_bib0001","first-page":"239","article-title":"Clinical and genetic heterogeneity in myotonic dystrophies","volume":"72","author":"Meola","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.06.011_bib0002","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cct.2011.11.016","article-title":"Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD)","volume":"33","author":"Hilbert","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.nmd.2022.06.011_bib0003","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: Molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2022.06.011_bib0004","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nmd.2022.06.011_bib0005","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/01.wnl.0000184585.93864.4e","article-title":"Similar brain tau pathology in DM2\/PROMM and DM1\/Steinert disease","volume":"65","author":"Maurage","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.06.011_bib0006","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/WNL.0b013e3181d8c35f","article-title":"Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2","volume":"74","author":"Weber","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.06.011_bib0007","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1093\/brain\/awr299","article-title":"The brain in myotonic dystrophy 1 and 2: Evidence for a predominant white matter disease","volume":"134","author":"Minnerop","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2022.06.011_bib0008","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.nmd.2021.06.002","article-title":"Cerebral involvement and related aspects in myotonic dystrophy type 2","volume":"31","author":"Peric","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.06.011_bib0009","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2017.05.013","article-title":"Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2","volume":"378","author":"Peric","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2022.06.011_bib0010","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s00415-010-5498-3","article-title":"Brain involvement in myotonic dystrophies: Neuroimaging and neuropsychological comparative study in DM1 and DM2","volume":"257","author":"Romeo","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2022.06.011_bib0011","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10072-016-2778-4","article-title":"Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2","volume":"38","author":"Peric","year":"2017","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nmd.2022.06.011_bib0012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2016.04.018","article-title":"Quality of life in patients with myotonic dystrophy type 2","volume":"365","author":"Rakocevic Stojanovic","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2022.06.011_bib0013","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/ejhg.2012.108","article-title":"Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2","volume":"20","author":"Kamsteeg","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2022.06.011_bib0014","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.06.011_bib0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00415-014-7545-y","article-title":"Frontostriatal dysexecutive syndrome: A core cognitive feature of myotonic dystrophy type 2","volume":"262","author":"Peric","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2022.06.011_bib0016","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00415-017-8574-0","article-title":"Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies","volume":"264","author":"Peric","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2022.06.011_bib0017","first-page":"231","article-title":"More on norms, reliability, and validity","volume":"41","author":"Burke","year":"1938","journal-title":"J Clin Psychol 1985"},{"key":"10.1016\/j.nmd.2022.06.011_bib0018","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/gps.1610","article-title":"The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening","volume":"21","author":"Mioshi","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.nmd.2022.06.011_bib0019","series-title":"Dijagnosti\u010dki testovi u neuropsihologiji","author":"Pavlovic","year":"2003"},{"key":"10.1016\/j.nmd.2022.06.011_bib0020","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archneur.1993.00540090024006","article-title":"Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests","volume":"50","author":"Chang","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2022.06.011_bib0021","series-title":"A compendium of neuropsychological tests: Administration, norms and commentary","author":"Spreen","year":"1991"},{"key":"10.1016\/j.nmd.2022.06.011_bib0022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13854049008401496","article-title":"Performance measures of 16- to 86-year-old males and females on the auditory verbal learning test","volume":"4","author":"Geffen","year":"1990","journal-title":"Clin Neuropsychol"},{"key":"10.1016\/j.nmd.2022.06.011_bib0023","article-title":"The assessment of aphasia and related disorders","author":"Goodglass","year":"1983","journal-title":"Philadelphia: Lea and Febiger;"},{"key":"10.1016\/j.nmd.2022.06.011_bib0024","first-page":"813","volume":"25","author":"Bosco","year":"2014"},{"key":"10.1016\/j.nmd.2022.06.011_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10072-007-0742-z","article-title":"Cognitive impairment in adult myotonic dystrophies: A longitudinal study","volume":"28","author":"Sansone","year":"2007","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nmd.2022.06.011_bib0026","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neurobiolaging.2019.11.013","article-title":"Basal forebrain metabolism in Alzheimer's disease continuum: relationship with education","volume":"87","author":"Nicolas","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nmd.2022.06.011_bib0027","doi-asserted-by":"crossref","first-page":"16808","DOI":"10.1038\/s41598-020-73911-6","article-title":"Disease progression modeling of Alzheimer's disease according to education level","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2022.06.011_bib0028","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ije\/dyz280","article-title":"Education, intelligence and Alzheimer's disease: Evidence from a multivariable two-sample Mendelian randomization study","volume":"49","author":"Anderson","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.nmd.2022.06.011_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130352","article-title":"Cortical and subcortical grey and white matter atrophy in myotonic dystrophies type 1 and 2 is associated with cognitive impairment, depression and daytime sleepiness","volume":"10","author":"Schneider-Gold","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2022.06.011_bib0030","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3389\/fneur.2019.01320","article-title":"Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2* Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla","volume":"10","author":"Ates","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2022.06.011_bib0031","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jnnp.2005.078451","article-title":"Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism","volume":"77","author":"Sansone","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2022.06.011_bib0032","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0960-8966(03)00137-8","article-title":"Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM\/DM-2)","volume":"13","author":"Meola","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.06.011_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213381","article-title":"Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study","volume":"14","author":"Gliem","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2022.06.011_bib0034","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.53.5.1042","article-title":"Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy","volume":"53","author":"Meola","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.06.011_bib0035","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1212\/WNL.0000000000002225","article-title":"Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2)","volume":"85","author":"Heatwole","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.06.011_bib0036","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s43441-020-00117-3","article-title":"Patient Input to Inform the Development of Central Nervous System Outcome Measures in Myotonic Dystrophy","volume":"54","author":"White","year":"2020","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.nmd.2022.06.011_bib0037","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.gaitpost.2015.12.020","article-title":"Comparison of temporal and stride characteristics in myotonic dystrophies type 1 and 2 during dual-task walking","volume":"44","author":"Radovanovi\u0107","year":"2016","journal-title":"Gait Posture"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622001973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622001973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:56Z","timestamp":1760775176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622001973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0960896622001973"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.06.011","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive assessment in patients with myotonic dystrophy type 2","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}